The invention relates to a pharmaceutical composition for treating or preventing acute and chronic inflammatory, allergic, post-traumatic, atrophic and hypertrophic diseases of the upper and lower respiratory tracts, and to the use thereof. The pharmaceutical composition comprises alcoholic tinctures of Tartarus stibiatus, Hepar sulfur, Euphrasia officinalis, Allium cepa and Arnica montana and an alcoholic solution of Apis mellifica, which are mixed with a physiologically acceptable carrier.

Methods of maintaining general oral care as well as reducing inflammation, pain, and bruising after oral surgery with a homeopathic recovery kit are disclosed.

A medicament to treat disordered functions of organs or tissues, as well as a wide range of diseases accompanied by disordering of the functions of organs or tissues. The medicament contains the original drug substance or the released-active form of the drug substance treated with bioelectric potentials which have been taken reading from the respective organ or tissue with normal functioning. The pharmaceutical drug substance or the released-active drug substance treated with bioelectric potentials can further be undergo successive multiple dilutions in a solvent selected from the group comprising water and a mixture of water and. The method of obtaining the drug involves exposing the drug substance or the released-active form of the drug substance to bioelectric potentials taken reading from the organ or tissue with normal functioning, with a further, optional successive multiple dilutions in a solvent.

The present disclosure provides for a customized topical formulation energized with quantum frequencies. In at least one aspect, the topical formulation contains a base formulation and a booster formulation. In another aspect of the topical formulation, the topical formulation is created by collecting data about a user and applying artificial intelligence (AI) and optimization models to the data to arrive at the custom and/or optimized topical formulation for the user.

A pyramidal meditation structure device includes a structure comprised of a plurality of vertical support beams oriented to define a pyramid of sufficient dimensions to house a person. The structure includes a plurality of walls each extending between a respective pair of the vertical support beams. An entrance is integrated into a respective one of the plurality of walls to enable the user to enter or exit the structure. A plurality of pipes is each attached to a respective one of the plurality of vertical support beams such that each of the plurality of pipes is positioned within the structure. A plurality of crystals is each integrated into a respective one of the plurality of pipes to enhance the ornamental appearance of the respective pipe thereby enabling the user to envision each of the sets of crystals as imparting healing energy into the user's meditation.

Compositions in homogenised powder form consisting of hydroxypropyl methylcellulose particles, and at least one chemical signalling agent in particle form, and optionally a biologically active agent, wherein the homogenised powder comprises particles having a mean particle diameter of 20 m to 500 mm uses and kits therefor.

Methods of producing a Hydrophilic Homeopathic Aqueous Substance Active (HASA)-gel matrix, include the steps of: (a) combining a homeopathic compound and an uninhibited aqueous composition to produce a HASA; (b) combining the HASA with at least one hydrophilic gelling agent; and (c) thereafter, forming the hydrophilic HASA-gel matrix by use of at least one of a thickening agent, a crosslinking agent, or a polymerization agent.